3 completed, 3 terminated, 1 recruiting. 7 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 3, Terminated 3, Recruiting 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow zileuton: new trials by email Literature Review of zileuton trials Research Report on zileuton
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zileuton for Food Allergy Zileuton extended release - Food Allergies | Phase 1 | Recruiting | Abigail Lang | 20 | 2026-11-03 | 2026-11-13 |
| Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia Zileuton (Zyflo®) Dasatinib (Sprycel®), Dosing with Zileuton/Dasatinib in CML, Daily dosing of Zileuton/Dasatinib - Chronic Myelogenous Leukemia | Phase 1 | Terminated | University of Massachusetts, Worcester | 2 | 2014-01-01 | 2016-09-30 |
| Trial of Zileuton CR in Children and Adults With Sickle Cell Disease Zileuton - Sickle Cell Disease | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 9 | 2010-09-01 | 2014-06-18 |
| Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers Zileuton, Celecoxib, laboratory biomarker analysis - Tobacco Use Disorder | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 84 | 2010-05-01 | 2015-04-02 |
| Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML. Zileuton - Chronic Myelogenous Leukemia | Phase 1 | Terminated | University of Massachusetts, Worcester | 2 | 2010-01-01 | 2015-05-27 |
| Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis | Phase 1 / Phase 2 | Terminated | National Human Genome Research Institute (NHGRI) | 3 | 2007-04-01 | 2013-08-02 |
| Safety Study of Zileuton Injection in Patients With Asthma Zileuton injection - Asthma | Phase 1 / Phase 2 | Completed | Critical Therapeutics | 60 | 2006-01-01 | 2007-09-26 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Albinism (1) · Albinism, Oculocutaneous (1) · Anaphylaxis (1) · Anemia, Sickle Cell (1) · Asthma (1) · Asthma, Exercise-Induced (1) · Food Hypersensitivity (1) · Hermanski-Pudlak Syndrome (1) · Leukemia (1) · Leukemia, Myeloid (1) · Lung Diseases (1) · Metabolic Diseases (1) · Myeloproliferative Disorders (1) · Platelet Storage Pool Deficiency (1)
University of Massachusetts, Worcester (2) · Abigail Lang (1) · Children's Hospital Medical Center, Cincinnati (1) · Critical Therapeutics (1) · National Cancer Institute (NCI) (1) · National Human Genome Research Institute (NHGRI) (1)
United States (7)
Jan Cerny, MD, PhD (2) · Dana Hilt, MD (1) · Powel Brown, MD (1) · Punam Malik, MD (1) · Thomas Markello, M.D. (1)
N01CN35159 (1)